Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression

Leonard Girnita1, Sudha K Shenoy, Bita Sehat

  • 1Department of Oncology and Pathology, Division of Cellular and Molecular Tumor Pathology, CCK, R8:04, Karolinska Hospital, SE-171 76 Stockholm, Sweden, and Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Leonard.Girnita@ki.se

Insights

Beta-arrestin1 links insulin-like growth factor-1 receptor (IGF-1R) to Mdm2 for degradation. New findings show IGF-1R stimulation also ubiquitinates beta-arrestin1, activating ERK signaling and regulating cell cycle progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Beta-arrestin1 acts as an adaptor protein in seven transmembrane receptor (7TMR) signaling.
  • Beta-arrestin1 facilitates the interaction between Mdm2 (an E3 ubiquitin ligase) and the insulin-like growth factor-1 receptor (IGF-1R), targeting IGF-1R for proteasomal degradation.

Purpose of the Study:

  • To investigate the role of beta-arrestin1 ubiquitination in insulin-like growth factor-1 receptor (IGF-1R) signaling.
  • To elucidate the downstream signaling pathways regulated by beta-arrestin1 in response to IGF-1R stimulation.
  • To determine the impact of beta-arrestin1-dependent signaling on cell cycle progression.

Main Methods:

  • Utilized human melanoma cells for experimental studies.
  • Employed siRNA-mediated suppression to reduce beta-arrestin1 levels.
  • Investigated the ubiquitination status of beta-arrestin1 following IGF-1R stimulation.
  • Assessed the activation of ERK1/2 signaling pathway.
  • Monitored cell cycle progression (G1 phase).

Main Results:

  • IGF-1R stimulation induces ubiquitination of beta-arrestin1.
  • Beta-arrestin1 ubiquitination is linked to regulation of vesicular trafficking and ERK1/2 activation.
  • Beta-arrestin1-dependent ERK activity can be independent of classical tyrosine kinase signaling.
  • siRNA-mediated suppression of beta-arrestin1 inhibited IGF-1-stimulated ERK activation and prolonged the G1 phase of the cell cycle in human melanoma cells.

Conclusions:

  • Beta-arrestin1 plays a crucial role in IGF-1R signaling beyond its role in receptor degradation.
  • Beta-arrestin1-dependent ERK signaling pathway is critical for regulating cell cycle progression.
  • This pathway represents a potential target for controlling the growth of normal and malignant cells.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...